Making AI a Partner in Neuroscientific Discovery

The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence data) has implications for people in many areas of human activity. A new perspective paper in the journal Neuron argues that like many professionals, neuroscientists can either benefit from partnering with these powerful tools or risk being left behind.

In their previous studies, the authors showed that important preconditions are met to develop LLMs that can interpret and analyze neuroscientific data like ChatGPT interprets language. These AI models can be built for many different types of data, including neuroimaging, genetics, single-cell genomics, and even hand-written clinical reports.

In the traditional model of research, a scientist studies previous data on a topic, develops new hypotheses and tests them using experiments. Because of the massive amounts of data available, scientists often focus on a narrow field of research, such as neuroimaging or genetics. LLMs, however, can absorb more neuroscientific research than a single human ever could. In their Neuron paper, the authors argue that one day LLMs specialized in diverse areas of neuroscience could be used to communicate with one another to bridge siloed areas of neuroscience research, uncovering truths that would be impossible to find by humans alone. In the case of drug development, for example, an LLM specialized in genetics could be used along with a neuroimaging LLM to discover promising candidate molecules to stop neurodegeneration. The neuroscientist would direct these LLMs and verify their outputs.

Lead author Danilo Bzdok mentions the possibility that the scientist will, in certain cases, not always be able to fully understand the mechanism behind the biological processes discovered by these LLMs.

"We have to be open to the fact that certain things about the brain may be unknowable, or at least take a long time to understand," he says. "Yet we might still generate insights from state-of-the-art LLMs and make clinical progress, even if we don’t fully grasp the way they reach conclusions."

To realize the full potential of LLMs in neuroscience, Bzdok says scientists would need more infrastructure for data processing and storage than is available today at many research organizations. More importantly, it would take a cultural shift to a much more data-driven scientific approach, where studies that rely heavily on artificial intelligence and LLMs are published by leading journals and funded by public agencies. While the traditional model of strongly hypothesis-driven research remains key and is not going away, Bzdok says capitalizing on emerging LLM technologies might be important to spur the next generation of neurological treatments in cases where the old model has been less fruitful.

"To quote John Naisbitt, neuroscientists today are ‘drowning in information but starving for knowledge,’" he says. "Our ability to generate biomolecular data is eclipsing our ability to glean understanding from these systems. LLMs offer an answer to this problem. They may be able to extract, synergize and synthesize knowledge from and across neuroscience domains, a task that may or may not exceed human comprehension."

Bzdok D, Thieme A, Levkovskyy O, Wren P, Ray T, Reddy S.
Data science opportunities of large language models for neuroscience and biomedicine.
Neuron. 2024 Feb 7:S0896-6273(24)00042-4. doi: 10.1016/j.neuron.2024.01.016

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...